rs6564851 — BCO1

BCO1 Upstream Variant — A Regulatory Brake on Beta-Carotene Conversion

The BCO1 gene encodes beta-carotene 15,15'-monooxygenase¹¹ beta-carotene 15,15'-monooxygenase
The enzyme that symmetrically cleaves one molecule of beta-carotene into two molecules of retinal, which is then reduced to retinol — the form of vitamin A used by the body, the key enzyme converting plant-based provitamin A into biologically active vitamin A. Most genetic studies of BCO1 focus on two coding variants — rs7501331 (Ala379Val) and rs12934922 (Arg267Ser) — that directly alter the enzyme's amino acid sequence. The rs6564851 variant operates at a different level entirely: located approximately 7.6 kb upstream of the BCO1 coding sequence, it is a regulatory SNP²² regulatory SNP
A non-coding variant that modifies gene expression or enzyme activity through changes to transcription factor binding sites, promoter elements, or chromatin accessibility rather than altering the protein sequence itself that emerged as the top genome-wide association signal for circulating beta-carotene levels across three independent cohorts.

The Mechanism

rs6564851 sits in an intergenic region at chromosome 16q23.2 (GRCh38 position 81,230,991), roughly 7.6 kb upstream from the BCO1 transcription start site — a location consistent with enhancer or promoter-proximal elements³³ enhancer or promoter-proximal elements
Regulatory DNA that can influence the transcription rate of a nearby gene; such elements often contain binding sites for transcription factors that activate or repress gene expression in a tissue-specific manner. The G allele is associated with reduced BCO1 enzyme activity. In a controlled pharmacokinetic study by Lietz et al. 2012⁴⁴ Lietz et al. 2012
Lietz G et al. Single nucleotide polymorphisms upstream from the β-carotene 15,15'-monoxygenase gene influence provitamin A conversion efficiency in female volunteers. J Nutr, 2012, the rs6564851 G allele was associated with a 48% reduction in BCMO1 catalytic activity in female volunteers. Carriers of the T allele (the better-converting allele) showed a positive correlation with the retinyl palmitate-to-beta-carotene ratio after a pharmacological beta-carotene dose (r = 0.41; P = 0.028), confirming that this upstream variant independently modulates the efficiency of the conversion step.

The net effect is a paradox that is characteristic of poor BCO1 converter status: because less beta-carotene is being cleaved, circulating beta-carotene levels rise while retinol production from plant sources falls. This is precisely what the GWAS data show — Ferrucci et al. 2009⁵⁵ Ferrucci et al. 2009
Ferrucci L et al. Common variation in the beta-carotene 15,15'-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study. Am J Hum Genet, 2009 found that each G allele is associated with a 0.27 standard deviation increase in plasma beta-carotene (p = 1.6 × 10⁻²⁴), while also reducing circulating lycopene, zeaxanthin, and lutein — a multi-carotenoid signature consistent with reduced cleavage activity across the entire carotenoid pathway.

BCO1 also possesses eccentric cleavage activity⁶⁶ eccentric cleavage activity
Asymmetric cleavage of carotenoids at positions other than 15,15', producing apo-carotenals and other bioactive metabolites including lycopene and lutein cleavage products; this secondary activity may explain why BCO1 variants affect non-beta-carotene carotenoids toward lycopene and other non-provitamin-A carotenoids, which explains the broader carotenoid profile changes seen with this variant beyond beta-carotene alone.

The Evidence

The founding association evidence comes from a multi-cohort GWAS by Ferrucci et al. 2009⁷⁷ Ferrucci et al. 2009
Ferrucci L et al. Common variation in the beta-carotene 15,15'-monooxygenase 1 gene affects circulating levels of carotenoids. Am J Hum Genet, 2009 in 3,941 participants across three studies (InCHIANTI, Women's Health and Aging Study, ATBC). The association with beta-carotene reached p = 1.6 × 10⁻²⁴ with effect sizes of 0.10–0.28 SDs per allele across multiple carotenoids. Importantly, plasma retinol itself showed no significant association — consistent with BCO1 impairment being compensated in people with mixed diets who obtain retinol directly from animal foods.

Mechanistic confirmation came from Lietz et al. 2012, who measured actual enzyme kinetics and pharmacokinetic responses in a controlled feeding study of female volunteers. The study was conducted exclusively in women — the functional activity reduction of 48% cannot be assumed to apply equally to males based on current data. Two nearby upstream variants (rs6420424, −59% activity; rs11645428, −51% activity) showed even larger effects, and all three variants together define a regulatory haplotype that substantially modulates BCO1 output independently of the coding variants.

The causal, not merely associative, nature of the rs6564851 effect on carotenoid metabolism was confirmed by a Mendelian randomization study by Perry et al. 2009⁸⁸ Perry et al. 2009
Perry JR et al. Circulating beta-carotene levels and type 2 diabetes — cause or effect? Diabetologia, 2009: the G allele raises circulating beta-carotene by 0.27 SD per allele as an instrumental variable, yet shows no association with type 2 diabetes (OR 0.98, 95% CI 0.93–1.04), confirming that the beta-carotene elevation reflects accumulation from reduced conversion, not higher dietary intake.

A small study by Feigl et al. 2014⁹⁹ Feigl et al. 2014
Feigl B et al. The relationship between BCMO1 gene variants and macular pigment optical density in persons with and without AMD. PLoS One, 2014 in 44 participants found that TT homozygotes had significantly higher macular pigment optical density than GG homozygotes (p < 0.01), consistent with the T allele facilitating better conversion and delivery of lutein and zeaxanthin to the macula. This effect was absent in AMD patients, possibly due to disease-related disruption of macular carotenoid transport.

Practical Implications

The central practical consequence is for people who rely on plant-based provitamin A. Dietary vitamin A comes in two forms: preformed retinol¹⁰¹⁰ preformed retinol
Found in animal products — liver, egg yolks, dairy, fatty fish — and absorbed directly without needing the BCO1 enzyme. The most reliable source for people with impaired beta-carotene conversion from animal sources and provitamin A carotenoids (primarily beta-carotene) from plants. G allele carriers convert less of their dietary beta-carotene to retinol; for omnivores, this is largely inconsequential because animal-source retinol bypasses BCO1 entirely. For vegans and vegetarians who rely exclusively on plant carotenoids for vitamin A, GG homozygosity represents a meaningful barrier to meeting vitamin A needs from diet alone.

The G allele is strikingly common in East Asian populations (~82% allele frequency), compared to ~51% in European and ~39% in African populations. This population difference is relevant in regions where plant-based diets are traditional — high G allele prevalence alongside plant-dominant diets may contribute to population-level vitamin A insufficiency patterns.

Macular health is a secondary concern: reduced BCO1 activity from the G allele may also lower the delivery of lutein and zeaxanthin to the retina, both of which are concentrated in the macula¹¹¹¹ macula
The central region of the retina responsible for sharp, detailed vision; its yellow pigmentation comes from concentrated lutein and zeaxanthin, which filter blue light and act as local antioxidants and protective against age-related macular degeneration.

Interactions

rs6564851 is on chromosome 16 (position 81,230,991), co-located with the BCO1 coding variants rs7501331 (Ala379Val) and rs12934922 (Arg267Ser). Although all three variants are in the BCO1 locus, the upstream regulatory variant and the coding variants represent distinct mechanisms — regulatory effects on expression versus structural effects on enzyme activity — and are expected to exert additive impairment when present together. Individuals carrying G alleles at rs6564851 alongside T alleles at rs7501331 and/or minor alleles at rs12934922 face cumulative BCO1 dysfunction combining both reduced enzyme quantity and reduced enzyme quality.

rs7834555, the other BCO1-related variant in the GeneOps database, is located on chromosome 8 (position 81,785,389) — a completely different chromosome from rs6564851. They are by definition not in linkage disequilibrium and represent fully independent genetic influences on carotenoid metabolism, likely through different biological mechanisms.

The broader regulatory haplotype at the rs6564851 locus includes rs6420424 and rs11645428, both of which show even larger activity reductions (59% and 51%, respectively) in the Lietz 2012 study. These three upstream variants likely tag the same or overlapping regulatory region and may be partially in LD with each other.